SARS-CoV-2感染后择期手术时机与风险评估:多学科共识更新
该多学科共识更新了SARS-CoV-2感染后择期手术时机的建议,指出疫苗接种和新变异株对围术期结局的影响尚不明确。核心推荐仍为感染后7周内避免择期手术,除非获益大于等待风险;7周内手术需个体化多学科风险评估,并强调无症状或轻症omicron感染并非无风险。
要点
- 感染SARS-CoV-2后7周内避免择期手术,除非获益超过等待风险。
- 7周内需手术者应行个体化多学科风险评估,包括基线死亡风险与风险修饰因素。
- 诊断SARS-CoV-2感染后10天内不应行择期手术,主要因传染性风险。
核心结论
- 感染后7周内避免择期手术,除非获益超过等待风险;7周内手术需个体化多学科风险评估。
- 诊断SARS-CoV-2感染后10天内不应行择期手术,主要因患者可能具有传染性。
- 无症状或轻症omicron感染不增加风险的假设目前缺乏依据。
研究设计与样本
- 由麻醉医师协会、围术期护理中心、外科专业协会联合会、皇家麻醉医师学院、英格兰皇家外科医师学院联合制定的多学科共识声明更新。
主要发现
- 既往变异株的无症状SARS-CoV-2感染在感染后6周内使围术期死亡风险增加三倍。
- 持续症状者和中重度COVID-19患者可能需要超过7周的延迟。
关键数值与推荐
- 择期手术应避免在SARS-CoV-2感染后7周内进行,除非获益超过等待风险。
- 择期手术不应在诊断SARS-CoV-2感染后10天内进行。
- 7周内手术的个体化风险评估应包括基线死亡风险计算和风险修饰因素评估(患者因素、SARS-CoV-2感染、手术因素)。
临床怎么用
- 术前评估应计算基线死亡风险并评估风险修饰因素。
- 应优化疫苗接种和功能状态,并开展共享决策。
- 对持续症状或中重度COVID-19患者考虑超过7周的延迟。
局限性
- 疫苗接种和新变异株对围术期结局的影响尚不明确。
- 建议聚焦omicron变异株和当前证据,随着新数据出现可能修订。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The impact of vaccination and new SARS-CoV-2 variants on peri-operative outcomes is unclear. We aimed to update previously published consensus recommendations on timing of elective surgery after SARS-CoV-2 infection to assist policymakers, administrative staff, clinicians and patients. The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting. We recommend individualised multidisciplinary risk assessment for patients requiring elective surgery within 7 weeks of SARS-CoV-2 infection. This should include baseline mortality risk calculation and assessment of risk modifiers (patient factors; SARS-CoV-2 infection; surgical factors). Asymptomatic SARS-CoV-2 infection with previous variants increased peri-operative mortality risk three-fold throughout the 6 weeks after infection, and assumptions that asymptomatic or mildly symptomatic omicron SARS-CoV-2 infection does not add risk are currently unfounded. Patients with persistent symptoms and those with moderate-to-severe COVID-19 may require a longer delay than 7 weeks. Elective surgery should not take place within 10 days of diagnosis of SARS-CoV-2 infection, predominantly because the patient may be infectious, which is a risk to surgical pathways, staff and other patients. We now emphasise that timing of surgery should include the assessment of baseline and increased risk, optimising vaccination and functional status, and shared decision-making. While these recommendations focus on the omicron variant and current evidence, the principles may also be of relevance to future variants. As further data emerge, these recommendations may be revised.
引用
- El-Boghdadly K, Cook TM, Goodacre T, et al. Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update: A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Centre for Perioperative Care, Federation of Surgical Specialty Associations, Royal College of Anaesthetists, Royal College of Surgeons of England. Anaesthesia. 2022. PMID: 35194788. doi:10.1111/anae.15699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。